...
首页> 外文期刊>The Biochemical Journal >Structure-function analysis of purified Enterococcus hirae CopB copper ATPase: effect of Menkes/Wilson disease mutation homologues.
【24h】

Structure-function analysis of purified Enterococcus hirae CopB copper ATPase: effect of Menkes/Wilson disease mutation homologues.

机译:纯化的平肠肠球菌CopB铜ATPase的结构功能分析:Menkes / Wilson疾病突变同源物的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

The Enterococcus hirae CopB ATPase (EC 3.6.1.3) confers copper resistance to the organism by expelling excess copper. Two related human ATPase genes, ATP7A (EC 3.6.1.36) and ATP7B (EC 3.6.1.36), have been cloned as the loci of mutations causing Menkes and Wilson diseases, diseases of copper metabolism. Many mutations in these genes have been identified in patients. Since it has not yet been possible to purify the human copper ATPases, it has proved difficult to test the impact of mutations on ATPase function. Some mutations occur in highly conserved sequence motifs, suggesting that their effect on function can be tested with a homologous enzyme. Here, we used the E. hirae CopB ATPase to investigate the impact of such mutations on enzyme function in vivo and in vitro. The Menkes disease mutation of Cys-1000-->Arg, changing the conserved Cys-Pro-Cys ('CPC') motif, was mimicked in CopB. The corresponding Cys-396-->Ser CopB ATPase was unable to restore copper resistance in a CopB knock-out mutant in vivo. The purified mutant ATPase still formed an acylphosphate intermediate, but possessed no detectable ATP hydrolytic activity. The most frequent Wilson disease mutation, His-1069-->Gln, was introduced into CopB as His-480-->Gln (H480Q). This mutant CopB also failed to confer copper resistance to a CopB knock-out strain. Purified H480Q CopB formed an acylphosphate intermediate and retained a small, but significant, ATPase activity. Our results reveal that Cys-396 and His-480 of CopB are key residues for ATPase function, and similar roles are suggested for Cys-1000 and His-1069 of Menkes and Wilson ATPases respectively.
机译:平肠肠球菌CopB ATPase(EC 3.6.1.3)通过排出过量的铜而使铜具有抗性。已将两个相关的人类ATPase基因ATP7A(EC 3.6.1.36)和ATP7B(EC 3.6.1.36)克隆为引起Menkes和Wilson疾病(铜代谢疾病)的突变位点。在患者中已经鉴定出这些基因中的许多突变。由于尚不能纯化人铜ATP酶,因此已证明难以测试突变对ATP酶功能的影响。一些突变发生在高度保守的序列基序中,这表明可以用同源酶测试其对功能的影响。在这里,我们使用了大肠杆菌(E. hirae)CopB ATPase来研究此类突变对体内和体外酶功能的影响。在CopB中模仿了Cys-1000-> Arg的Menkes疾病突变,改变了保守的Cys-Pro-Cys('CPC')基序。相应的Cys-396-> Ser CopB ATPase无法恢复体内CopB敲除突变体的铜抗性。纯化的突变型ATPase仍形成酰基磷酸酯中间体,但没有可检测的ATP水解活性。最常见的Wilson疾病突变His-1069-> Gln被引入到CopB中,称为His-480-> Gln(H480Q)。该突变体CopB也未能赋予铜抗CopB敲除菌株的能力。纯化的H480Q CopB形成了酰基磷酸酯中间体,并保留了一个很小但很重要的ATPase活性。我们的结果表明,CopB的Cys-396和His-480是ATPase功能的关键残基,而Menkes和Wilson Wilson ATPase的Cys-1000和His-1069的作用相似。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号